NYSE$SLQT
Selectquote Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
SelectQuote outperformed expectations for the 9th consecutive quarter and raised fiscal year 2024 guidance ranges.
SelectQuote reported consolidated revenue for the third quarter of fiscal year 2024 of $376.4 million and net income of $8.6 million. The company raised its fiscal year 2024 revenue guidance to a range of $1.25 billion to $1.3 billion and adjusted EBITDA to a range of $100 million to $110 million.
- SelectQuote outperformed expectations for the 9th consecutive quarter.
- Senior business completed a highly successful Medicare Advantage busy season, with over 185,000 Americans finding the right Medicare Advantage policy.
- Healthcare Services business saw SelectRx grow by over 12,000 members, significantly exceeding the original outlook.
- Holistic healthcare platform created new customers at a highly efficient revenue to customer acquisition cost of over 4x.
Headline financials
Revenue & EPS history
SelectQuote · Revenue · Quarterly
$376M
Revenue by segment
SelectQuote · $128M total across 2 segments · Q1 2024
- Senior$89.9M+16.0%70.4%
- Life$37.8M+2.7%29.6%
Forward guidance
SelectQuote raised its fiscal year 2024 guidance ranges.
Tailwinds
- Revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion
- Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million
- Adjusted EBITDA* expected in a range of $100 million to $110 million vs prior range of $90 million to $105 million
- NULL
- NULL
Headwinds
- NULL
- NULL
- NULL
- NULL
- NULL
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
-2.4%
Avg return
Earnings day
+1.1%
Avg return
5 days after
+2.2%
Avg return
30 days after
57%
17 / 30 earnings
Positive
+75.5%
Q2 2023
Best reaction
-49.0%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -8.9% | +39.9% | +24.3% | |
| Q2 2026 | -29.0% | -37.4% | -47.9% | |
| Q1 2026 | +0.0% | -16.8% | -29.3% | |
| Q3 2025 | -12.1% | -14.2% | -15.4% | |
| Q2 2025 | +30.8% | +37.0% | -17.4% | |
| Q1 2025 | +6.9% | +16.7% | +46.1% | |
| Q4 2024 | -49.0% | -44.6% | -37.6% | |
| Q3 2024 | +4.8% | +12.4% | +13.2% | |
| Q2 2024 | +6.3% | +40.5% | +64.0% | |
| Q1 2024 | -4.3% | -5.8% | -3.6% | |
| Q4 2023 | -16.2% | -16.9% | -8.8% | |
| Q3 2023 | +11.1% | -16.7% | +16.7% | |
| Q2 2023 | +75.5% | +128.8% | +181.1% | |
| Q1 2023 | +9.5% | +9.2% | +17.7% | |
| Q4 2022 | -30.4% | -47.5% | -54.9% | |
| Q3 2022 | +7.5% | +0.4% | +20.4% | |
| Q2 2022 | -48.0% | -55.4% | -60.1% | |
| Q1 2022 | -22.3% | -17.8% | -36.3% | |
| Q4 2021 | -44.6% | -37.6% | -7.2% | |
| Q3 2020 | -21.5% | -22.2% | -23.4% | |
| Q3 2021 | -21.9% | -23.2% | -26.6% | |
| Q2 2020 | +7.7% | +9.2% | +7.4% | |
| Q2 2021 | +7.7% | +9.2% | +7.4% | |
| Q1 2020 | +2.7% | +7.7% | +20.3% | |
| Q1 2021 | +7.6% | +10.5% | +23.0% | |
| Q4 2018 | +10.9% | +12.0% | -2.1% | |
| Q4 2019 | +10.9% | +12.0% | -2.1% | |
| Q3 2019 | +10.9% | +12.0% | -2.1% | |
| Q2 2019 | +10.9% | +12.0% | -2.1% | |
| Q4 2020 | +14.2% | +20.1% | +0.3% | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro